Word from the Dark Side – junk food decline, limestone mine, naked whine and employers benign
Ozempic Could Crush the Junk Food Industry. But It Is Fighting Back.
Ozempic users like Taylor aren’t just eating less. They’re eating differently. GLP-1 drugs seem not only to shrink appetite but to rewrite people’s desires. They attack what Amy Bentley, a food historian and professor at New York University, calls the industrial palate: the set of preferences created by our acclimatization, often starting with baby food, to the tastes and textures of artificial flavors and preservatives. Patients on GLP-1 drugs have reported losing interest in ultraprocessed foods, products that are made with ingredients you wouldn’t find in an ordinary kitchen: colorings, bleaching agents, artificial sweeteners and modified starches. Some users realize that many packaged snacks they once loved now taste repugnant. “Wegovy destroyed my taste buds,” a Redditor wrote on a support group, adding: “And I love it.”
Read MoreGiven Big Food’s track record, it’s likely that the companies will succeed at finding products Ozempic users crave. But what if they’re too successful? I asked Nicole Avena, a professor of neuroscience at Mount Sinai who studies sugar addiction, if she believed it could be possible for food companies to engineer, intentionally or not, compounds that would make GLP-1 drugs less effective. Avena told me it was plausible. The food industry, she pointed out, has cabinets of formidable reward-triggering compounds with which to experiment. Companies could end up counteracting the drugs to some degree in their efforts to make foods more rewarding, she said.









